Godrej Agrovet files SEBI takeover disclosure for Astec LifeSciences

M&A / JV 17 Jun 2026 · Announced· ✓ Verified

The NSE filing confirms submission of a formal disclosure by/for Godrej Agrovet relating to Astec LifeSciences under the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Regulation 31(4) requires disclosure of acquisition of shares or voting rights exceeding prescribed thresholds. The filing date (17 June 2026) signals the commencement of regulatory notification. Full offer details, consideration, and shareholding percentages are not available in public search results and require access to the full disclosure document.

Why it mattersReg 31(4) disclosure signals either a 25% threshold crossing (triggering mandatory open offer under Reg 35) or an open offer announcement; verify the exact shareholding % and offer price from the formal disclosure document to assess offer timeline and SEBI approval gating.
SectorPharma & Healthcare
[object Object][object Object][object Object][object Object][object Object][object Object][object Object]

Sources

Open in the live tracker →

Related deals